Aspire-lakewood Holdings, Inc. ASBP
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-02-18 |
| Shares Out. | 1,400,000 |
| Website | ir.aspirebiolabs.com ↗ |
| Phone | 13026587581 |
| Revenue | $63,104 |
| Gross Profit | $12,286 |
| Net Income | -$1.3M |
| Free Cash Flow | -$7.2M |
| Total Assets | $13.5M |
| Total Liabilities | $1.8M |
| Equity | $11.8M |
About Aspire-lakewood Holdings, Inc.
Aspire-Lakewood Holdings Inc is a United States-based company. Along with its subsidiary, it is involved in the design and manufacture of engineered automotive and industrial control systems that combine mechanical engineering, electronics, and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a powertrain-agnostic product portfolio that includes mechatronic actuators, human-machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates around 11 manufacturing facilities globally and serves as a tier-one automotive supplier to OEMs and other industrial firms.
Aspire-lakewood Holdings, Inc. is a publicly traded company under the ticker symbol ASBP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.